Literature DB >> 18295813

Activation of the glucocorticoid receptor releases unstimulated PBMCs from an early block in HIV-1 replication.

Klaus Wiegers1, Doreen Schwarck, Rudolph Reimer, Wolfgang Bohn.   

Abstract

Infection of resting peripheral mononuclear blood cells (PBMCs) with HIV-1 is not productive due to a block prior to integration of the provirus into the host genome. Here we show that a unique restriction is determined by the status of the glucocorticoid receptor (GR). Proviral integration increases after addition of a GR ligand. The ligand dependent effect is confined to an early time period after infection and requires GR and the GR binding viral protein Vpr. Endogenous GR and transiently expressed Vpr are localized in the cytoplasm in unstimulated PMCs and comigrate into the nucleus upon ligand addition. Thus, the predominant cytoplasmic localization of GR seems to be a specific obstacle for HIV replication. Accordingly, efficient proviral integration in a cell line with a constitutive cytoplasmic GR requires addition of a GR ligand. The data suggest that steroids can overcome the restriction on HIV provirus formation and thereby increase the reservoir of virus producing cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295813     DOI: 10.1016/j.virol.2008.01.037

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

Review 1.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

2.  Host genes associated with HIV-1 replication in lymphatic tissue.

Authors:  Anthony J Smith; Qingsheng Li; Stephen W Wietgrefe; Timothy W Schacker; Cavan S Reilly; Ashley T Haase
Journal:  J Immunol       Date:  2010-10-08       Impact factor: 5.422

3.  Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound.

Authors:  Michael J Corley; Alina P S Pang; Thomas A Rasmussen; Martin Tolstrup; Ole S Søgaard; Lishomwa C Ndhlovu
Journal:  AIDS       Date:  2021-11-15       Impact factor: 4.177

4.  Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.

Authors:  Richard P H Huijbregts; E Scott Helton; Katherine G Michel; Steffanie Sabbaj; Holly E Richter; Paul A Goepfert; Zdenek Hel
Journal:  Endocrinology       Date:  2013-01-25       Impact factor: 4.736

5.  PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.

Authors:  K Tan; R Roda; L Ostrow; J McArthur; A Nath
Journal:  Neurology       Date:  2009-01-07       Impact factor: 9.910

Review 6.  HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.

Authors:  Michael Kogan; Jay Rappaport
Journal:  Retrovirology       Date:  2011-04-13       Impact factor: 4.602

7.  Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?

Authors:  Carlo Contoreggi; George P Chrousos; Michele Di Mascio
Journal:  Neurobehav HIV Med       Date:  2016-12-28

Review 8.  PTSD co-morbid with HIV: Separate but equal, or two parts of a whole?

Authors:  Gretchen N Neigh; Siara T Rhodes; Arielle Valdez; Tanja Jovanovic
Journal:  Neurobiol Dis       Date:  2015-12-01       Impact factor: 5.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.